Cytochrome P450 3A5

Summary
UniProt ID
P20815
Gene Symbol
  • CYP3A5
Organism
Homo sapiens (human)
External Links
GlyGen
P20815
PubChem
P20815
SwissLipids
The Human Metabolome Database
HMDBP01554
The O-GlcNAc Database
P20815
O-GlcNAcAtlas
P20815
Sequence
MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKFDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISLAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYSMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSLFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSIIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVVNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFSKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQGLLQPEKPIVLKVDSRDGTLSGE
Glycosylation Sites
Displaying 1 entry
Position Description PubMed ID GlyTouCan ID Source
278
Feature
  • ProtVista GlyGen : Glycosylation Site from GlyGen
  • ProtVista UniProt : Glycosylation Site from UniProt
Pathway
Displaying all 2 entries
Pathway Name Organism
Aflatoxin activation and detoxification Homo sapiens
Xenobiotics Homo sapiens
Disease
Displaying entries 131 - 140 of 170 in total
DO ID Disease Name Source
DOID:5556 testicular malignant germ cell cancer
DOID:557 kidney disease
DOID:5603 T-cell acute lymphoblastic leukemia
DOID:5604 adult acute lymphocytic leukemia
DOID:5672 large intestine cancer
DOID:574 peripheral nervous system disease
DOID:5773 oral submucous fibrosis
DOID:580 uric acid nephrolithiasis
DOID:5842 testis seminoma
DOID:585 nephrolithiasis

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024